NASDAQ •
Healthcare •
Medical Devices •
Quote as of 08/03/2026 16:00
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization451.94 mln
Float26.27 mln
Earnings Date08/03/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
1.71
Highly suspicious
Relative Strength
69
/ 100
Outperforming
Debt / Equity
3.38
Highly leveraged
ROE
-142
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
ClearPoint Neuro is a US-based medical device company that develops and sells tools for minimally invasive brain surgery. Its product lineup includes hardware, software, and disposable instruments that help surgeons plan procedures, guide devices to precise targets within the brain, and monitor progress in real time. The company also sells laser therapy and fluid exchange systems, and provides consulting support to pharmaceutical and medical technology partners navigating clinical and regulatory processes. Founded in 1998 and based in Solana Beach, California, ClearPoint Neuro works alongside several academic and industry partners to advance the field of neurological treatment.
